Search for: "Gilead Sciences, Inc.,"
Results 1 - 20
of 181
Sort by Relevance
|
Sort by Date
6 Apr 2024, 8:52 pm
This year's conference co-chairs include MJ Edwards (Senior Associate General Counsel, Patent Prosecution Team Lead, Gilead Sciences Inc.), Nicole Woods (Vice President, Assistant General Patent Counsel, Eli Lilly and Company), and Mercedes Meyer (Partner, Banner Witcoff LLP). [read post]
29 Feb 2024, 5:17 pm
On June 27, 2023, the PTO issued two ORDER TO SHOW CAUSE letters (here and here) to Gilead Sciences Inc. [read post]
27 Feb 2024, 7:08 pm
The first multiple PTE case up-to-bat concerns Gilead Sciences Inc. [read post]
27 Feb 2024, 1:29 pm
Gilead Sciences Inc. [read post]
22 Jan 2024, 9:00 am
About Truvada Truvada is manufactured by the California biopharma company Gilead Sciences Inc. [read post]
21 Nov 2023, 6:30 am
The companies improving their scores to join the Trendsetter ranks this year are Meta Platforms Inc.; Alliant Energy Corp.; American Electric Power Company Inc.; Archer Daniels Midland Co.; Celanese Corp.; CMS Energy Corp.; Equinix Inc.; Fifth Third Bancorp; Freeport-McMoRan Inc.; Gilead Sciences Inc.; PG&E Corp.; Pinnacle West Capital Corp.; Prologis Inc.; Public Service Enterprise Group; Raytheon Technologies Corp.;… [read post]
21 Nov 2023, 6:30 am
The companies improving their scores to join the Trendsetter ranks this year are Meta Platforms Inc.; Alliant Energy Corp.; American Electric Power Company Inc.; Archer Daniels Midland Co.; Celanese Corp.; CMS Energy Corp.; Equinix Inc.; Fifth Third Bancorp; Freeport-McMoRan Inc.; Gilead Sciences Inc.; PG&E Corp.; Pinnacle West Capital Corp.; Prologis Inc.; Public Service Enterprise Group; Raytheon Technologies Corp.;… [read post]
11 Oct 2023, 1:47 am
Jane LambertPatents Court (Mr Justice Meade) Gilead Sciences Inc and another NuCana PLC [2023] EWHC 611 (Pat) (21 March 2023)This was an action by Gilead Sciences Inc. and its British subsidiary Gilead Sciences Ltd ("Gilead") for revocation of two European Patents (UK) that had been granted to NuCana Plc ("NoCana"), namely EP 2955 190 B1… [read post]
5 Sep 2023, 2:39 am
Cellect Strategies Some stakeholders have been expecting a decision like Cellect since the Federal Circuit first decided that a later-granted patent can raise OTDP issues for an earlier-granted patent, in its 2014 decision in Gilead Sciences, Inc. v. [read post]
23 Mar 2023, 6:00 am
Gilead Sciences., Inc., CAFC 2021-2168 Gilead Sciences filed a petition for Inter Partes Review (IPR) against the University of Minnesota’s U.S. patent No. 8,815,830 (the ’830 Patent). [read post]
8 Mar 2023, 2:51 pm
Subject matter This appeal pertains to an inter partes review (“IPR”) in which Gilead Sciences, Inc. [read post]
7 Mar 2023, 9:16 pm
Gilead Sciences, Inc., the Federal Circuit reminded us that the principles and considerations that form the basis for the Federal Circuit's recent enablement jurisprudence originated in that Court's analysis of the other side of Section 112(a), the written description requirement. [read post]
15 Dec 2022, 11:18 am
Gilead Sciences Inc. [read post]
15 Sep 2022, 2:13 am
Notably, Article 1360 had never been applied in practice since 2006, the year of enactment of Part IV of the Civil Code covering IP rights.Interestingly, several months before this amendment, the Government issued an order allowing a Russian legal entity, “Pharmasyntez”, to use Remdesivir, an antiviral medication used for treatment of Covid-19, without authorization of the patent owner, Gilead Sciences, Inc. [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
4 Jul 2022, 6:00 am
A proposal at Gilead Sciences received 49.9% support. [read post]
4 Jul 2022, 6:00 am
A proposal at Gilead Sciences received 49.9% support. [read post]
27 Jun 2022, 9:01 pm
A proposal at Gilead Sciences received 49.9% support. [read post]
19 Apr 2022, 5:05 am
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
31 Mar 2022, 10:50 am
The Justice Department will reportedly probe at least a dozen pharmaceutical companies such as Gilead Sciences Inc, Johnson & Johnson and GlaxoSmithKline PLC’s ViiV Healthcare. [read post]
